vs

Side-by-side financial comparison of PARKE BANCORP, INC. (PKBK) and TriSalus Life Sciences, Inc. (TLSI). Click either name above to swap in a different company.

PARKE BANCORP, INC. is the larger business by last-quarter revenue ($22.7M vs $13.2M, roughly 1.7× TriSalus Life Sciences, Inc.). PARKE BANCORP, INC. runs the higher net margin — 48.8% vs -73.9%, a 122.6% gap on every dollar of revenue. On growth, TriSalus Life Sciences, Inc. posted the faster year-over-year revenue change (59.8% vs 35.7%). PARKE BANCORP, INC. produced more free cash flow last quarter ($39.0M vs $-2.5M). Over the past eight quarters, TriSalus Life Sciences, Inc.'s revenue compounded faster (43.0% CAGR vs 22.6%).

Parke Bancorp, Inc. is a U.S. regional bank holding company operating Parke Bank. It offers commercial and retail banking services including deposit products, mortgage loans, small business financing and personal lending, primarily serving customers across New Jersey and the Philadelphia metropolitan area.

TriSalus Life Sciences, Inc. is a clinical-stage biotechnology company focused on advancing immuno-oncology and interventional oncology solutions. It develops proprietary targeted drug delivery technologies designed to improve treatment efficacy for patients with liver, pancreatic and other hard-to-treat solid tumors, primarily operating in North American markets via partnerships with clinical care and research institutions.

PKBK vs TLSI — Head-to-Head

Bigger by revenue
PKBK
PKBK
1.7× larger
PKBK
$22.7M
$13.2M
TLSI
Growing faster (revenue YoY)
TLSI
TLSI
+24.2% gap
TLSI
59.8%
35.7%
PKBK
Higher net margin
PKBK
PKBK
122.6% more per $
PKBK
48.8%
-73.9%
TLSI
More free cash flow
PKBK
PKBK
$41.5M more FCF
PKBK
$39.0M
$-2.5M
TLSI
Faster 2-yr revenue CAGR
TLSI
TLSI
Annualised
TLSI
43.0%
22.6%
PKBK

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
PKBK
PKBK
TLSI
TLSI
Revenue
$22.7M
$13.2M
Net Profit
$11.1M
$-9.8M
Gross Margin
86.7%
Operating Margin
64.2%
-24.8%
Net Margin
48.8%
-73.9%
Revenue YoY
35.7%
59.8%
Net Profit YoY
49.8%
3.5%
EPS (diluted)
$0.93
$-0.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PKBK
PKBK
TLSI
TLSI
Q4 25
$22.7M
$13.2M
Q3 25
$21.0M
$11.6M
Q2 25
$18.7M
$11.2M
Q1 25
$17.4M
$9.2M
Q4 24
$16.8M
$8.3M
Q3 24
$15.6M
$7.3M
Q2 24
$15.5M
$7.4M
Q1 24
$15.1M
$6.5M
Net Profit
PKBK
PKBK
TLSI
TLSI
Q4 25
$11.1M
$-9.8M
Q3 25
$10.6M
$-10.8M
Q2 25
$8.3M
$-8.3M
Q1 25
$7.8M
$-10.4M
Q4 24
$7.4M
$-10.1M
Q3 24
$7.5M
$-2.4M
Q2 24
$6.5M
$-4.3M
Q1 24
$6.2M
$-13.2M
Gross Margin
PKBK
PKBK
TLSI
TLSI
Q4 25
86.7%
Q3 25
83.5%
Q2 25
83.9%
Q1 25
83.7%
Q4 24
85.3%
Q3 24
86.3%
Q2 24
87.6%
Q1 24
85.0%
Operating Margin
PKBK
PKBK
TLSI
TLSI
Q4 25
64.2%
-24.8%
Q3 25
64.2%
-77.9%
Q2 25
59.0%
-65.4%
Q1 25
59.1%
-79.9%
Q4 24
58.0%
-91.8%
Q3 24
60.2%
-118.9%
Q2 24
56.7%
-111.0%
Q1 24
55.4%
-180.8%
Net Margin
PKBK
PKBK
TLSI
TLSI
Q4 25
48.8%
-73.9%
Q3 25
50.6%
-93.5%
Q2 25
44.3%
-73.9%
Q1 25
44.6%
-113.2%
Q4 24
44.2%
-122.4%
Q3 24
48.1%
-32.6%
Q2 24
41.6%
-58.8%
Q1 24
40.7%
-204.5%
EPS (diluted)
PKBK
PKBK
TLSI
TLSI
Q4 25
$0.93
$-0.22
Q3 25
$0.89
$-0.96
Q2 25
$0.69
$-0.27
Q1 25
$0.65
$-0.39
Q4 24
$0.61
$-0.38
Q3 24
$0.62
$-0.12
Q2 24
$0.53
$-0.21
Q1 24
$0.51
$-0.60

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PKBK
PKBK
TLSI
TLSI
Cash + ST InvestmentsLiquidity on hand
$20.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$324.5M
$-33.9M
Total Assets
$2.2B
$35.3M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PKBK
PKBK
TLSI
TLSI
Q4 25
$20.4M
Q3 25
$22.7M
Q2 25
$26.5M
Q1 25
$13.0M
Q4 24
$8.5M
Q3 24
$11.3M
Q2 24
$16.5M
Q1 24
$4.0M
Stockholders' Equity
PKBK
PKBK
TLSI
TLSI
Q4 25
$324.5M
$-33.9M
Q3 25
$314.8M
$-26.7M
Q2 25
$312.2M
$-19.4M
Q1 25
$305.9M
$-34.4M
Q4 24
$300.1M
$-25.9M
Q3 24
$296.5M
$-20.4M
Q2 24
$292.8M
$-25.3M
Q1 24
$288.4M
$-36.0M
Total Assets
PKBK
PKBK
TLSI
TLSI
Q4 25
$2.2B
$35.3M
Q3 25
$2.2B
$36.5M
Q2 25
$2.2B
$41.3M
Q1 25
$2.1B
$28.6M
Q4 24
$2.1B
$24.0M
Q3 24
$2.1B
$27.5M
Q2 24
$2.0B
$32.4M
Q1 24
$2.0B
$17.9M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PKBK
PKBK
TLSI
TLSI
Operating Cash FlowLast quarter
$39.6M
$-2.5M
Free Cash FlowOCF − Capex
$39.0M
$-2.5M
FCF MarginFCF / Revenue
171.3%
-19.1%
Capex IntensityCapex / Revenue
2.6%
0.3%
Cash ConversionOCF / Net Profit
3.57×
TTM Free Cash FlowTrailing 4 quarters
$63.5M
$-19.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PKBK
PKBK
TLSI
TLSI
Q4 25
$39.6M
$-2.5M
Q3 25
$11.4M
$-3.7M
Q2 25
$6.8M
$-7.3M
Q1 25
$7.0M
$-4.5M
Q4 24
$35.2M
$-5.7M
Q3 24
$9.4M
$-10.8M
Q2 24
$8.9M
$-13.4M
Q1 24
$8.3M
$-10.9M
Free Cash Flow
PKBK
PKBK
TLSI
TLSI
Q4 25
$39.0M
$-2.5M
Q3 25
$11.2M
$-3.9M
Q2 25
$6.7M
$-7.4M
Q1 25
$6.6M
$-5.3M
Q4 24
$35.0M
$-5.8M
Q3 24
$9.4M
$-11.0M
Q2 24
$8.9M
$-13.5M
Q1 24
$8.3M
$-10.9M
FCF Margin
PKBK
PKBK
TLSI
TLSI
Q4 25
171.3%
-19.1%
Q3 25
53.5%
-33.9%
Q2 25
35.8%
-66.1%
Q1 25
38.0%
-57.3%
Q4 24
209.1%
-69.7%
Q3 24
60.0%
-149.9%
Q2 24
57.1%
-183.1%
Q1 24
55.1%
-169.3%
Capex Intensity
PKBK
PKBK
TLSI
TLSI
Q4 25
2.6%
0.3%
Q3 25
0.5%
1.9%
Q2 25
0.3%
0.8%
Q1 25
2.2%
8.2%
Q4 24
0.7%
0.6%
Q3 24
0.1%
2.3%
Q2 24
0.2%
0.8%
Q1 24
0.1%
1.0%
Cash Conversion
PKBK
PKBK
TLSI
TLSI
Q4 25
3.57×
Q3 25
1.07×
Q2 25
0.82×
Q1 25
0.90×
Q4 24
4.75×
Q3 24
1.25×
Q2 24
1.38×
Q1 24
1.36×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons